Cancer genomic medicine in Japan and the roles of pharmacists

被引：1

作者：

Aomori, Tohru ^{[1
,2
]}

Sakurai, Hiroomi ^{[2
]}

Nishihara, Hiroshi ^{[3
]}

机构：

[1] Keio Univ, Div Hosp Pharm Sci, Fac Pharm, Tokyo, Japan

[2] Keio Univ Hosp, Dept Pharm, Tokyo, Japan

[3] Keio Univ, Keio Canc Ctr, Genom Unit, Sch Med, Tokyo, Japan

来源：

PHARMACOGENETICS AND GENOMICS | 2022年 / 32卷 / 06期

关键词：

cancer genomic medicine; precision medicine;

D O I：

10.1097/FPC.0000000000000476

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Cancer genomic medicine (CGM) is a medical service that provides optimized treatment for each patient based on genes, biomarkers, environment, and lifestyle. In Japan, the approval of designed core hospitals for CGM started in 2017. In June 2019, two types of cancer gene panel tests became available in the national health insurance system, and CGM was socially implemented. While CGM is still in its infancy and there are some issues that need to be resolved, there are cases where the treatment has shown dramatic results. The present review highlights the CGM system in Japan, the issues it faces, and the role of pharmacists in this system.

引用

页码：242 / 245

页数：4

共 50 条

[41] Genomic medicine - Hereditary colorectal cancer
Lynch, HT
de la Chapelle, A
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10): : 919 - 932
[42] Genomic medicine meets cancer interception
Domchek, Susan M.
CANCER RESEARCH, 2022, 82 (12)
[43] Development of Nationwide Genomic Screening Project (LC-SCRUM-Japan) for the Establishment of Cancer Precision Medicine
Goto, Koichi
ANNALS OF ONCOLOGY, 2017, 28 : 5 - 5
[44] Unique roles of nanotechnology in medicine and cancer
Alam, F.
Naim, M.
Aziz, M.
Yadav, N.
INDIAN JOURNAL OF CANCER, 2014, 51 (04) : 506 - U387
[45] Roles of Exosome Genomic DNA in Colorectal Cancer
Li, Xiaoshuai
Wang, Qiushi
Wang, Rui
FRONTIERS IN PHARMACOLOGY, 2022, 13
[46] The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan
Akatsuka, Jun
Kimura, Go
Takadate, Mami
Hiraoka, Sayuri
Sahara, Tomoko
Iwai, Takuma
Hasegawa, Hiroya
Mikami, Hikaru
Obayashi, Kotaro
Takeda, Hayato
Endo, Yuki
Toyama, Yuka
Yamamoto, Yoichiro
Yamada, Takeshi
Kondo, Yukihiro
JOURNAL OF NIPPON MEDICAL SCHOOL, 2024, 91 (05)
[47] Cancer genetics or cancer genomics in the era of genomic medicine?
Daly, PA
ANNALS OF ONCOLOGY, 2003, 14 : 19 - 25
[48] The framework of cancer precision medicine in Japan
Yatabe, Yasushi
ANNALS OF ONCOLOGY, 2021, 32 : S240 - S240
[49] The Japan premiere of the cancer genome medicine
Tsuchihara, Katsuya
Tanabe, Minoru
CANCER SCIENCE, 2018, 109 : 1211 - 1211
[50] A segmentation analysis for pharmacists' and patients' views of pharmacists' roles
Schommer, Jon C.
Gaither, Caroline A.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (03): : 508 - 528

← 1 2 3 4 5 →